FDA Class II · Drug · May 20, 2026
Buprenorphine Hydrochloride recall — ENDO USA, Inc.
Crystallization; identified as Buprenorphine free base
Official ID D-0527-2026 · Official record ↗
ENDO USA recalls
Recall found. ENDO USA is named in FDA Class II recall D-0527-2026 covering Buprenorphine Hydrochloride. Hazard: Crystallization; identified as Buprenorphine free base Identifying details: Lot #: 84132, Exp 02/28/2027; 87693, Exp 03/31/2027. Status: Ongoing.
Models with recalls
All ENDO USA recalls
Verify with the official sources:
- CPSC — consumer products ↗ (aggregated here)
- NHTSA — vehicles, car seats, tires ↗ (aggregated here; use NHTSA's VIN lookup to check a specific vehicle)
- FDA — food, drugs, medical devices ↗ (aggregated here)
- USDA FSIS — meat, poultry & processed egg products ↗ (not aggregated here)
- Recalls.gov — the U.S. government’s all-agency portal ↗
Found something wrong or missing? Report a data error.
Compiled from official public-domain government data. Last checked October 22, 2026 at 6:00 PM UTC.